MAPT and Alzheimer disease: Brain-specific deletion of the insulin receptor in mice results in glycogen synthase kinase 2 beta activation resulting in hyperphosphorylation of tau protein, a hallmark of early Alzheimer's Disease (AD) (Schubert et al., 2004).